Palmaz Scientific faces accusations of misleading investors

Investment bank Jefferies & Co. and a bankrupt company founded by the inventor of the first heart stent are in a dispute over accusations of improper stock sales, the San Antonio Express-News reports. 

Lawyers representing Jefferies have accused Palmaz Scientific of listing Jefferies on its marketing materials after the companies severed ties. A lawyer for Palmaz Scientific, which was founded by Julio Palmaz, MD, said Jefferies never terminated its contract with the company.

Read more at the link below:

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.